These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9111209)

  • 41. Mutational activation of c-Ha-ras gene in squamous cell carcinomas of rat Zymbal gland induced by carcinogenic heterocyclic amines.
    Kudo M; Ogura T; Esumi H; Sugimura T
    Mol Carcinog; 1991; 4(1):36-42. PubMed ID: 2009133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
    Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
    Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spontaneous mutation in lacI transgenic mice: a comparison of tissues.
    de Boer JG; Provost S; Gorelick N; Tindall K; Glickman BW
    Mutagenesis; 1998 Mar; 13(2):109-14. PubMed ID: 9568581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutagenicity of heterocyclic amines when activated by pancreas tissue.
    Lawson T; Kolar C
    Mutat Res; 1994 Dec; 325(4):125-8. PubMed ID: 7527903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mlh1-dependent suppression of specific mutations induced in vivo by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP).
    Smith-Roe SL; Hegan DC; Glazer PM; Buermeyer AB
    Mutat Res; 2006 Feb; 594(1-2):101-12. PubMed ID: 16256150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutational spectra of tamoxifen-induced mutations in the livers of lacI transgenic rats.
    Davies R; Oreffo VI; Bayliss S; Dinh PA; Lilley KS; White IN; Smith LL; Styles JA
    Environ Mol Mutagen; 1996; 28(4):430-3. PubMed ID: 8991074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of colon tumors in C57BL/6J mice fed MeIQx, IQ, or PhIP followed by dextran sulfate sodium treatment.
    Nishikawa A; Imazawa T; Kuroiwa Y; Kitamura Y; Kanki K; Ishii Y; Umemura T; Hirose M
    Toxicol Sci; 2005 Apr; 84(2):243-8. PubMed ID: 15635146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice.
    Sørensen IK; Mortensen A; Kristiansen E; van Kreijl C; Adamson RH; Thorgeirsson SS
    Carcinogenesis; 1996 Oct; 17(10):2221-7. PubMed ID: 8895492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carcinogenicity in mice and rats of heterocyclic amines in cooked foods.
    Ohgaki H; Hasegawa H; Kato T; Suenaga M; Ubukata M; Sato S; Takayama S; Sugimura T
    Environ Health Perspect; 1986 Aug; 67():129-34. PubMed ID: 3757948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Organ variation in the mutagenicity of MeIQ in Big Blue lacI transgenic mice.
    Suzuki T; Hayashi M; Ochiai M; Wakabayashi K; Ushijima T; Sugimura T; Nagao M; Sofuni T
    Mutat Res; 1996 Jul; 369(1-2):45-9. PubMed ID: 8700181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specificity of mutations induced by the food-associated heterocyclic amine 2-amino-1-methyl-6-phenylimidazo-[4,5-b]-pyridine in colon cancer cell lines defective in mismatch repair.
    Glaab WE; Kort KL; Skopek TR
    Cancer Res; 2000 Sep; 60(17):4921-5. PubMed ID: 10987307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of mutations by 2-acetylaminofluorene in lacI transgenic B6C3F1 mouse liver.
    Ross JA; Leavitt SA
    Mutagenesis; 1998 Mar; 13(2):173-9. PubMed ID: 9568591
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single nucleotide instability: a wide involvement in human and rat mammary carcinogenesis?
    Okochi E; Watanabe N; Sugimura T; Ushijima T
    Mutat Res; 2002 Sep; 506-507():101-11. PubMed ID: 12351149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
    Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
    Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Specific mutational spectrum of dimethylnitrosamine in the lacI transgene of Big Blue C57BL/6 mice.
    Wang X; Suzuki T; Itoh T; Honma M; Nishikawa A; Furukawa F; Takahashi M; Hayashi M; Kato T; Sofuni T
    Mutagenesis; 1998 Nov; 13(6):625-30. PubMed ID: 9862195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spontaneous mutations in the Big Blue transgenic system are primarily mouse derived.
    Hill KA; Buettner VL; Glickman BW; Sommer SS
    Mutat Res; 1999 Jan; 436(1):11-9. PubMed ID: 9878678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 32P-post-labelling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification.
    Pfau W; Brockstedt U; Söhren KD; Marquardt H
    Carcinogenesis; 1994 May; 15(5):877-82. PubMed ID: 8200090
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-dependent formation of preneoplastic foci and DNA adducts in rat liver with 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
    Hasegawa R; Takahashi S; Shirai T; Iwasaki S; Kim DJ; Ochiai M; Nagao M; Sugimura T; Ito N
    Carcinogenesis; 1992 Aug; 13(8):1427-31. PubMed ID: 1499093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High potency of bioactivation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mouse colon epithelial cells with Apc(Min) mutation.
    Bellocq D; Molina J; Rathahao E; Canlet C; Taché S; Martin PG; Pierre F; Paris A
    Mutat Res; 2008 May; 653(1-2):34-43. PubMed ID: 18434241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induces genetic changes in murine intestinal tumours and cells with ApcMin mutation.
    Andreassen A; Vikse R; Mikalsen A; Adamovic T; Steffensen IL; Hjertholm H; Levan G; Alexander J
    Mutat Res; 2006 Apr; 604(1-2):60-70. PubMed ID: 16574467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.